The Japanese Biochemical Society/The Molecular Biology Society of Japan

ConBio2017

ConBio2017

Dec 6, 2017 - Dec 9, 2017
Kobe Port Island(Kobe International Conference Center, Kobe Portopia Hotel, Kobe International Exhibition Hall, The Kobe Chamber of Commerce and Industry)

[1P-0976] A receptor-type protein tyrosine phosphatase PTPRK inhibits CD133-dependent tumor growth and drug-resistance of colon cancer cells via dephosphorylation of CD133.

〇Yusuke Mori1,2, Osamu Shimozato1,3, Kyosuke Uchiumi1,2, Meijie Sang1, Takahiro Inoue2,4, Toshinori Ozaki1,2 (1.Chiba Cancer Ctr. Res. Inst. Lab. of DNA Damage signaling, 2.Dept. of Mol. Biol. and Oncol., Chiba Univ. Sch. of Med., 3.Chiba Cancer Ctr. Res. Inst. Lab. of Oncogenomics, 4.Chiba Cancer Ctr. Res. Inst. Lab. of DNA Cancer Genetics)

CD133、PTPRK、phosphatase、colon cancer

This archive has moved to the member page of The Molecular Biology Society of Japan and The Japanese Biochemical Society.
Members of the either society can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

Password